ReadyRx
ReadyRx states its price does not change with dose. It names no dispensing pharmacy for this drug, publishes no titration schedule, publishes no cancellation terms a reader can reach, does not say beside the figure whether the drug is compounded or branded, never says the medication is inside the figure.
Ellis Brandt built this site’s grading methodology and maintains it. Last re-read September 2026.
The figure this seller publishes
$249 per month — standing rate
The seller states this figure does not change with dose: any dose — the seller prices the plan for all doses and prints no mg at all. It covers shipping, unlimited messaging, nutrition support.
The standing monthly rate after the discounted first month, covering all doses. A quarterly option is offered on the same toggle but is not priced in this window.
Read September 2026 from https://readyrx.com/treatments/se.
What kind of figure it is
It is a standing rate charged per month, and what it buys is any dose — the seller prices flat. The seller’s own words for the cycle are “/mo.”, and the words that tie the figure to what it buys are “Treatment Options No hidden fees, ever Monthly Quarterly All Doses $229/first month $249/mo. after”.
This is one of 2 figures this seller publishes whose basis it states. It was chosen by a stated rule that never reads the amount: prefer a figure readable without starting an intake, then one read on a page filed under its own molecule, then the lowest offer id. Every rankable figure it publishes states what the figure buys.
What the page states, and what it leaves out
No pharmacy language on the page at all. The seller states this figure does not change with dose: any dose — the seller prices the plan for all doses and prints no mg at all. The figure covers shipping, unlimited messaging, nutrition support. The page does not say whether the drug is compounded or branded. One of 2 figures this seller publishes whose basis it states. Read September 2026 from https://readyrx.com/treatments/se.
Cancellation
Cancellation terms exist in this seller's page markup but are not rendered to a reader. This site treats that as unpublished: text no reader can see is not a term this seller has stated.
It makes no unconditional “cancel anytime” claim. It names no way to cancel. No notice period is stated. No minimum term is stated. No refund position is stated. Automatic renewal is not disclosed. The terms are not on the page that carries the price. Read September 2026.
Dose escalation
This seller does not print the titration steps its patients follow. 54 of the 60 sellers whose figure states what it buys do not either. What the four FDA-approved labels set as the escalation is published on this site with no provider named and no paid link.
Sub-score inputs
The four disclosure sub-scores, computed from this seller's own read fields. No letter grade and no weighted total is published on this site: the weights are provisional and are not signed off. These are inputs, not a rating.
- price transparency
- 7.0
- pharmacy disclosure
- 0.0
- what's included
- 3.0
- cancellation terms
- 0.0
Every point is for something this seller put on its own page. How we grade publishes the four dimensions, what each one is scored on and the points each is worth.
Go to ReadyRx
ReadyRx pays this site nothing. The link below is unpaid and carries no tracking of any kind. It goes to the page that carries the figure quoted above.
Visit siteWhere this seller is listed
One board per buying decision. Each is the same table with the columns that decision needs, under its own dated and counted title.
- Semaglutide providers54 listed, September 2026
Readers who have settled on semaglutide and are choosing who to buy it from.
- Tirzepatide providers52 listed, September 2026
Readers who have settled on tirzepatide and are choosing who to buy it from.
- Providers that publish a price before the intake59 listed, September 2026
Readers who will not start an intake without seeing a standing rate and what it covers.
- GLP-1 providers with a published price, compared59 listed, September 2026
Readers whose first question is the number, and who want to see what each figure actually buys before comparing them.
- GLP-1 providers for readers paying cash52 listed, September 2026
Readers who are paying out of pocket and need the medication itself inside the published figure, not just the consult.
- GLP-1 telehealth providers60 listed, September 2026
Readers choosing a prescriber rather than a price — who dispenses, what the plan includes, and how to leave it.